These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8477771)

  • 1. Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report.
    Harland SJ; Cook PA; Fosså SD; Horwich A; Parkinson MC; Roberts JT; Stenning SP
    Eur Urol; 1993; 23(1):115-8; discussion 119. PubMed ID: 8477771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group.
    Harland SJ; Cook PA; Fossa SD; Horwich A; Mead GM; Parkinson MC; Roberts JT; Stenning SP
    J Urol; 1998 Oct; 160(4):1353-7. PubMed ID: 9751353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumour. Results of the German multicentre study.
    Loy V; Dieckmann KP
    Eur Urol; 1993; 23(1):120-2. PubMed ID: 8386640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer.
    Berthelsen JG; Skakkebaek NE; von der Maase H; Sørensen BL; Mogensen P
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1683-6. PubMed ID: 6129027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
    Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
    Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms.
    Dieckmann KP; Loy V
    J Clin Oncol; 1996 Dec; 14(12):3126-32. PubMed ID: 8955658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the other testis be biopsied?
    Daugaard G; Giwercman A; Skakkebaek NE
    Semin Urol Oncol; 1996 Feb; 14(1):8-12. PubMed ID: 8833382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
    Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
    J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular carcinoma in situ in subfertile Danish men.
    Olesen IA; Hoei-Hansen CE; Skakkebaek NE; Petersen JH; Rajpert-De Meyts E; Jørgensen N
    Int J Androl; 2007 Aug; 30(4):406-11; discussion 412. PubMed ID: 17705813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of a contralateral second carcinoma in patients with testicular tumors caused by testicular carcinoma in situ].
    Kleinschmidt K; Weissbach L; Holstein AF
    Urologe A; 1989 Sep; 28(5):281-4. PubMed ID: 2573191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy.
    Dieckmann KP; Kulejewski M; Pichlmeier U; Loy V
    Eur Urol; 2007 Jan; 51(1):175-83; discussion 183-5. PubMed ID: 16814456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the testis: review of biological and clinical features.
    Dieckmann KP; Skakkebaek NE
    Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the contralateral testis be biopsied? Round table discussion.
    Grigor KM; Rørth M
    Eur Urol; 1993; 23(1):129-35. PubMed ID: 8477772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of carcinoma in situ of the testis in 207 oligozoospermic men from infertile couples: prospective study of testicular biopsies.
    Giwercman A; Thomsen JK; Hertz J; Berthelsen JG; Jensen V; Meinecke B; Thormann L; Storm HH; Skakkebaek NE
    BMJ; 1997 Oct; 315(7114):989-91. PubMed ID: 9365296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral testicular cancer.
    Bischof EF; Herold AH; Marty PJ
    J Am Board Fam Pract; 1994; 7(6):516-9. PubMed ID: 7847115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
    Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
    Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and clinical aspects of carcinoma in situ of the testis.
    Giwercman A; von der Maase H; Skakkebaek NE
    Eur Urol; 1993; 23(1):104-10; discussion 111-4. PubMed ID: 8477770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
    Maroto P; García Del Muro X; Valverde C; Pinto A; Sanchez A; Guma J; Alonso T; Martínez Del Prado P; Vazquez S; Mellado B; Aparicio J; Fernandez-Aramburo A; Girones R; Terrasa J;
    Urol Oncol; 2021 Feb; 39(2):135.e17-135.e23. PubMed ID: 33189529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy.
    Fosså SD; Aass N; Heilo A; Daugaard G; E Skakkebaek N; Stenwig AE; Nesland JM; Looijenga LH; Oosterhuis JW
    Ann Oncol; 2003 Sep; 14(9):1412-8. PubMed ID: 12954581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of small testicular tumors relative to carcinoma in situ prevalence.
    Huyghe E; Soulie M; Escourrou G; Mieusset R; Plante P; Thonneau P
    J Urol; 2005 Mar; 173(3):820-3. PubMed ID: 15711277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.